- Home
- ZURA vs DSP Comparison
ZURA vs DSP Comparison
Compare ZURA & DSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZURA | DSP |
|---|---|---|
| Founded | 2022 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 137.2M | 184.3M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | ZURA | DSP |
|---|---|---|
| Price | $3.51 | $11.17 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 9 |
| Target Price | $11.38 | ★ $19.44 |
| AVG Volume (30 Days) | ★ 408.9K | 309.8K |
| Earning Date | 11-13-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 29.49 |
| EPS | N/A | ★ 0.10 |
| Revenue | N/A | ★ $324,131,000.00 |
| Revenue This Year | N/A | $16.39 |
| Revenue Next Year | N/A | $14.89 |
| P/E Ratio | ★ N/A | $113.53 |
| Revenue Growth | N/A | ★ 22.97 |
| 52 Week Low | $0.97 | $8.11 |
| 52 Week High | $4.68 | $26.33 |
Technical Indicators
Market Signals| Indicator | ZURA | DSP |
|---|---|---|
| Relative Strength Index (RSI) | 44.69 | 68.32 |
| Support Level | $3.57 | $10.38 |
| Resistance Level | $3.95 | $11.40 |
| Average True Range (ATR) | 0.27 | 0.57 |
| MACD | -0.07 | 0.13 |
| Stochastic Oscillator | 0.43 | 88.94 |
Price Performance
Historical ComparisonAbout ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.
About DSP Viant Technology Inc.
Viant Technology Inc is an advertising software company. The software enables the programmatic purchase of advertising, which is the electronification of the advertising buying process. It operates a cloud-based demand side platform ("DSP") that is used by marketers and its advertising agencies to centralize the planning, buying and measurement of its advertising across channels, including connected TV (CTV), streaming audio, digital out-of-home, mobile and desktop.